Patent · US Expired

Humanized antibody

US7456260B2 · kind B2 · utility

49Cited by
9References
40Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 17, 2003
Grant dateNov 25, 2008
Priority date
Expiry dateJul 17, 2024

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The current invention provides new human variable chain framework regions and humanized antibodies comprising the framework regions. The invention also provides a new method of identifying framework acceptor regions in framework sequences for backmutation to graft a donor sequence to the human framework.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.